Skip to main content

Volume 34 - Issue 6 - June, 2022

06/01/2022
Table of Contents for the Journal of Invasive Cardiology's June 2022 issue.
Table of Contents for the Journal of Invasive Cardiology's June 2022 issue.
Table of Contents for the...
06/01/2022
Journal of Invasive Cardiology
Original Contribution
05/06/2022
Marcello De Giosa; Gennaro Sardella, MD, PhD; Giuseppe G.L. Biondi-Zoccai, MD, PhD; Antonio L. Bartorelli, MD; Francesco Bedogni, MD, PhD; Sergio Berti, MD; Martino Pepe, MD, PhD; Palma Luisa Nestola, MD; Alberto Morello, MD; Alessandro Iadanza, MD; Carmen Spaccarotella, MD; Arturo Giordano, MD, PhD; Michele Cimmino, MD; Nicola Corcione, MD; Michele Albanese, MD; Paolo Ferraro, MD
The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...
The differential outcomes between pure/predominant aortic stenosis (AS) and mixed aortic valve disease (MAVD) in patients undergoing transcatheter aortic valve implantation (TAVI) are still debated. The aim of this analysis was to evaluate...
The differential outcomes...
05/06/2022
Journal of Invasive Cardiology
Original Contribution
06/01/2022
Scott M. Lilly, MD, PhD; Michael Biersmith, MD; Maurice Alston, DO; Nader Makki, MD; Hoda Hatoum, PhD; Konstantinos Dean Boudoulas, MD; Breandan Yeats, BS; Obiora Egbuche, MD; Medha Biswas, MD; David Orsinelli, MD; Lakshmi Dasi, PhD
In patients with transcatheter aortic valve implantation (TAVI), accurate assessment of gradients is important to assess valve function and durability, which drives clinical decision-making. In this comparison, the authors sought to evaluate...
In patients with transcatheter aortic valve implantation (TAVI), accurate assessment of gradients is important to assess valve function and durability, which drives clinical decision-making. In this comparison, the authors sought to evaluate...
In patients with transcatheter...
06/01/2022
Journal of Invasive Cardiology
Original Contribution
05/11/2022
Grace Halupnik, MD; Nicholas Fedele, MD; Katie Comp, MD; Emma-Marie Taleb, MD; Andrew N. Shammas, BS , OMS, MD; Susan Jones-Miller, MD, MS; Venkat Shankarraman, MD, PhD; Nicolas W. Shammas, MD, MS, FACC, FSCAI, FACP, FSVM; Gail A. Shammas, BSN, BS , RN, BSc
The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the investigational device exemption study. At present, real-world data are not available. The...
The Auryon 355-nm laser atherectomy system (AngioDynamics, Inc) showed a low rate of target-lesion revascularization (TLR) at 6-month follow-up in the investigational device exemption study. At present, real-world data are not available. The...
The Auryon 355-nm laser...
05/11/2022
Journal of Invasive Cardiology
Original Contribution
05/19/2022
Michael E. Ring, MD; Robert W. Hodson, MD; Michael C. Reed, MD; Sameer A. Gafoor, MD; Matthew D. Forrester, BS, MD; Ruyun Jin, MD; Emily J. Cox, PhD; Branden R. Reynolds, MD; Brydan D. Curtis, DO; Gary L. Grunkemeier, PhD
Patients with small aortic annuli (SAA) are prone to higher post-transcatheter aortic valve replacement (TAVR) transvalvular gradients and development of prosthesis-patient mismatch (PPM). In many patients with SAA, the choice of TAVR valve...
Patients with small aortic annuli (SAA) are prone to higher post-transcatheter aortic valve replacement (TAVR) transvalvular gradients and development of prosthesis-patient mismatch (PPM). In many patients with SAA, the choice of TAVR valve...
Patients with small aortic...
05/19/2022
Journal of Invasive Cardiology
Original Research
05/19/2022
Christian W. Hamm, MD, PhD, FESC; Won-Keun Kim, MD; Matthias Renker, MD; Holger Nef, MD; Helge Möllmann, MD, PhD; Thomas Walther, MD, PhD; Yeong-Hoon Choi, MD, PhD
Data are lacking regarding the outcomes of balloon postdilation (BPD) for the Acurate neo and neo2 devices. The aim of this study was to assess the impact of BPD in a large, single-center cohort of patients treated with the Acurate platform.
Data are lacking regarding the outcomes of balloon postdilation (BPD) for the Acurate neo and neo2 devices. The aim of this study was to assess the impact of BPD in a large, single-center cohort of patients treated with the Acurate platform.
Data are lacking regarding the...
05/19/2022
Journal of Invasive Cardiology
Original Contribution
06/01/2022
Sehrish Memon, MD; Evan Friend, BS, MD; Sanjog Kalra, MD; Sean Janzer, MD; Jon C. George, MD, MBA
Three-dimensional (3D) printing for subclavian artery (SA) percutaneous vascular interventions (PVI) may allow superior understanding of patient specific complex anatomy and aid with preprocedural planning.
Three-dimensional (3D) printing for subclavian artery (SA) percutaneous vascular interventions (PVI) may allow superior understanding of patient specific complex anatomy and aid with preprocedural planning.
Three-dimensional (3D) printing...
06/01/2022
Journal of Invasive Cardiology
Original Research
06/01/2022
Selina Vlieger, MSc; Jin M. Cheng, MD, PhD; Rohit M. Oemrawsingh, MD, PhD; Auke P.J.D. Weevers, MD; Jawed Polad, MD; Ben Gho, MD, PhD; Martijn Meuwissen, MD, PhD; Eric Boersma, PhD; Peter den Heijer, MD, PhD; Alexander JJ. IJsselmuiden, MD, PhD
Randomized controlled trials for in-stent restenosis (ISR) and de novo lesions in small-diameter vessels have shown promising results, but data on DCB use in real-world practice are still scarce. The aim of the PEARL (Paclitaxel-Eluting...
Randomized controlled trials for in-stent restenosis (ISR) and de novo lesions in small-diameter vessels have shown promising results, but data on DCB use in real-world practice are still scarce. The aim of the PEARL (Paclitaxel-Eluting...
Randomized controlled trials for...
06/01/2022
Journal of Invasive Cardiology
Original Contribution
06/01/2022
Eric A. Secemsky, MD, MSc, RPVI, FACC, FAHA, FSCAI; Ehrin J. Armstrong, MD, MSc, FACC; Stefanos Giannopoulos, MD
The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...
The application of 2 distinct and simultaneously applied drug-delivery platforms for the treatment of peripheral artery disease has not been studied. This study investigated the outcomes of femoropopliteal disease treated with drug-coated...
The application of 2 distinct...
06/01/2022
Journal of Invasive Cardiology
Rapid Communication
06/01/2022
Hady Lichaa, MD
Many techniques have been developed to minimize the risk of contrast-induced nephropathy (CIN) in patients with chronic kidney disease (CKD) through drastic reductions in iodinated contrast volume and the use of intravascular ultrasound...
Many techniques have been developed to minimize the risk of contrast-induced nephropathy (CIN) in patients with chronic kidney disease (CKD) through drastic reductions in iodinated contrast volume and the use of intravascular ultrasound...
Many techniques have been...
06/01/2022
Journal of Invasive Cardiology